Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€463.95
25.01.21
€500.00
25.01.22
15.42%
26.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
WatchMen 
25.01.21 0%
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€304.50
13.12.21
€330.00
13.12.22
-25.91%
24.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
geldnutzer 
13.12.21 60%
sell
Illumina Inc.

Start price
Target price
Perf. (%)
€364.50
11.01.22
-
11.01.23
-8.29%
21.01.22

Probably not worthwhile Investment
tinelchen 
11.01.22 0%
buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€130.34
27.02.21
-
27.02.22
37.81%
20.01.22

Innovative
Medium risks for its business
Top 10 in its market
Future proof or reliable business model
Troubadour 
27.02.21 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.31
19.01.21
€67.00
19.01.22
14.53%
20.01.22

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Snowman 
19.01.21 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€41.11
09.11.21
€60.00
09.11.22
14.73%
19.01.22

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Snowman 
09.11.21 70%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€173.98
25.01.21
€250.00
25.01.22
23.00%
17.01.22

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
gerihouse 
25.01.21 90%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.22
12.01.22
€240.00
12.01.23
-0.90%
12.01.22

Could be worthwhile Investment >10% per year
Known brand
phonebroker 
12.01.22 50%
buy
Medtronic plc

Start price
Target price
Perf. (%)
€97.71
10.01.21
-
10.01.22
-2.05%
11.01.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Known brand
Maxfloh 
10.01.21 20%
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€60.00
31.12.20
€78.00
31.12.21
10.17%
01.01.22

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
stepdown 
31.12.20 80%
sell
Johnson & Johnson

Start price
Target price
Perf. (%)
€147.94
22.12.21
-
22.12.25
1.31%
28.12.21

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
Gilbert 
22.12.21 50%
sell
Biogen Inc.

Start price
Target price
Perf. (%)
€243.10
18.10.21
€210.00
02.01.23
-12.53%
16.12.21

Could be worthwhile Investment >10% per year
IfYouCanDreamItYouCanDoIt 
18.10.21 60%
buy
Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€142.00
13.12.20
€170.00
13.12.21
9.00%
14.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
skatcup 
13.12.20 100%
sell
Incyte Corp.

Start price
Target price
Perf. (%)
€67.64
24.02.21
-
24.02.22
-12.39%
25.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Dependend from some customers or products
SpringheelJack 
24.02.21 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€442.80
23.11.20
€555.00
23.11.21
29.97%
24.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
geldnutzer 
23.11.20 80%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€500.00
22.11.21
7.75%
23.11.21

marge 
22.11.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.40
18.11.20
-
18.11.21
45.06%
19.11.21

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Low dividend yield expected
shadow 
18.11.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€29.35
15.03.21
€50.00
15.03.22
43.43%
09.11.21

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Snowman 
15.03.21 80%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€177.98
22.10.20
€170.00
04.11.21
-6.03%
05.11.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
geldnutzer 
22.10.20 50%
buy
Thermo Fisher Scientific Inc.

Start price
Target price
Perf. (%)
€406.60
22.10.20
€580.00
04.11.21
37.09%
05.11.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
geldnutzer 
22.10.20 50%
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€85.17
14.08.20
€120.00
04.11.21
31.44%
05.11.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth > 30% per year expected
Espresso 
14.08.20 50%
buy
Medtronic plc

Start price
Target price
Perf. (%)
€85.25
10.08.20
-
04.11.21
22.82%
05.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Normal challenges to pay loans and raise capital
ROE higher than 15% per year
AktienPeter 
10.08.20 50%
buy
Baxter International

Start price
Target price
Perf. (%)
€77.61
01.07.20
€80.00
04.11.21
-12.10%
05.11.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Known brand
gerihouse 
01.07.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.87
08.06.20
€65.00
04.11.21
-18.67%
05.11.21

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
gerihouse 
08.06.20 60%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€131.66
06.06.20
€205.00
04.11.21
77.81%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
06.06.20 50%